Literature DB >> 28804739

Selection of Genetically Modified Bacteriophages Using the CRISPR-Cas System.

Miriam Manor1, Udi Qimron1.   

Abstract

We present a CRISPR-Cas based technique for deleting genes from the T7 bacteriophage genome. A DNA fragment encoding homologous arms to the target gene to be deleted is first cloned into a plasmid. The T7 phage is then propagated in Escherichia coli harboring this plasmid. During this propagation, some phage genomes undergo homologous recombination with the plasmid, thus deleting the targeted gene. To select for these genomes, the CRISPR-Cas system is used to cleave non-edited genomes, enabling isolation of the desired recombinant phages. This protocol allows seamless deletion of desired genes in a T7 phage, and can be expanded to other phages and other types of genetic manipulations as well.

Entities:  

Keywords:  Bacteriophage; Escherichia coli; Homologous recombination; Positive selection

Year:  2017        PMID: 28804739      PMCID: PMC5553622          DOI: 10.21769/BioProtoc.2431

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  17 in total

Review 1.  Marine viruses--major players in the global ecosystem.

Authors:  Curtis A Suttle
Journal:  Nat Rev Microbiol       Date:  2007-10       Impact factor: 60.633

Review 2.  Bacteriophages for the treatment of Pseudomonas aeruginosa infections.

Authors:  D R Harper; M C Enright
Journal:  J Appl Microbiol       Date:  2011-04-18       Impact factor: 3.772

Review 3.  Genetically Engineered Phages: a Review of Advances over the Last Decade.

Authors:  Diana P Pires; Sara Cleto; Sanna Sillankorva; Joana Azeredo; Timothy K Lu
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-01       Impact factor: 11.056

4.  Genome Engineering of Virulent Lactococcal Phages Using CRISPR-Cas9.

Authors:  Marie-Laurence Lemay; Denise M Tremblay; Sylvain Moineau
Journal:  ACS Synth Biol       Date:  2017-03-30       Impact factor: 5.110

5.  Functional Analysis of Bacteriophage Immunity through a Type I-E CRISPR-Cas System in Vibrio cholerae and Its Application in Bacteriophage Genome Engineering.

Authors:  Allison M Box; Matthew J McGuffie; Brendan J O'Hara; Kimberley D Seed
Journal:  J Bacteriol       Date:  2015-11-23       Impact factor: 3.490

6.  Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.

Authors:  Robert J Citorik; Mark Mimee; Timothy K Lu
Journal:  Nat Biotechnol       Date:  2014-09-21       Impact factor: 54.908

7.  Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria.

Authors:  Ido Yosef; Miriam Manor; Ruth Kiro; Udi Qimron
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-18       Impact factor: 11.205

8.  Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system.

Authors:  Ruth Kiro; Dror Shitrit; Udi Qimron
Journal:  RNA Biol       Date:  2014-01-22       Impact factor: 4.652

9.  CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.

Authors:  Bruno Martel; Sylvain Moineau
Journal:  Nucleic Acids Res       Date:  2014-07-24       Impact factor: 16.971

10.  Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

Authors:  David Bikard; Chad W Euler; Wenyan Jiang; Philip M Nussenzweig; Gregory W Goldberg; Xavier Duportet; Vincent A Fischetti; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2014-10-05       Impact factor: 54.908

View more
  3 in total

Review 1.  Phage Genetic Engineering Using CRISPR⁻Cas Systems.

Authors:  Asma Hatoum-Aslan
Journal:  Viruses       Date:  2018-06-19       Impact factor: 5.048

2.  Engineered K1F bacteriophages kill intracellular Escherichia coli K1 in human epithelial cells.

Authors:  Christian Møller-Olsen; Siu Fung Stanley Ho; Ranti Dev Shukla; Tamas Feher; Antonia P Sagona
Journal:  Sci Rep       Date:  2018-12-03       Impact factor: 4.379

3.  Targeted Genome Editing of Virulent Phages Using CRISPR-Cas9.

Authors:  Marie-Laurence Lemay; Ariane C Renaud; Geneviève M Rousseau; Sylvain Moineau
Journal:  Bio Protoc       Date:  2018-01-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.